Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

Natalia Pin Chuen Zing, Thais Fischer, Eliana Miranda, Maria Almeida Dias, Yung Gonzaga, Renata Lyrio R Baptista, Guilherme D Amarante, Rony Schaffel, Frederico Lisboa Nogueira, Davimar Bortucchi, Rodrigo Santucci, Sergio Brasil, Karin Z Cecyn, Vera Figueiredo, Nelson S Castro, Yana S Rabelo, Gilnara Fontinele Silva, Abrahão Elias Hallack Neto, Patricia Giacon, Milene Matedi, Diego Vila Cle, Juliana Pereira, Fernando Barroso, Renata R Souza, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela, Ana Carolina Oliver, Laura Korin, Macarena Roa, Camila Peña, Maria Alejandra Torres Viera, Alana Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Eduardo Edelman Saul, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino De Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 3064.

https://doi.org/10.1182/blood-2024-211630

Published: 2024

Journal Articles

The Impact of Social Determinants and Diagnostic Inequities in Hodgkin Lymphoma Outcomes: A Comparative Analysis of South America and the United States

Blood (2024) 144 (Supplement 1): 2370.

https://doi.org/10.1182/blood-2024-203230

Published: 2024

Journal Articles

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Thais Fischer, Eliana Miranda, Juliana Pereira, Guilherme Duffles, Jamila Vaz Tavarez, Nelson S Castro, Rodrigo Santucci, Danielle Leão Cordeiro De Farias, Sergio Brasil, Claudio G Macedo, Carolina Colaco, Renata Lyrio R Baptista, Karin Z Cecyn, Davimar Bortucchi, Gilnara Fontinele Silva, Samir Nabhan, Patricia Giacon, Rony Schaffel, Natalia Pin Chuen Zing, Frederico Lisboa Nogueira, Ademar Dantas Cunha, Diego Vila Cle, Jose D Tadeu, Vera Figueiredo, Mateus Dalló Dal Pont, Rafael Gaiolla, Nelson Hamerschlak, Eduardo Flavio Oliveira Ribeiro, Abrahão Elias Hallack Neto, Maria Almeida Dias, Yung Gonzaga, Yana S Rabelo, Larissa Lane Teixeira, Guilherme Fleury Perini, Milene Matedi, Priscilla Cury, Henry Idrobo, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valverte, Luis Mario Villela Martinez, Ana Carolina Oliver, Laura Korin, Camila Peña, Macarena Roa, Maria Alejandra Torres, Seisha Alana von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Casey Bermack, Kelly Meza, Bryan Valcarcel, Carmino A Souza, Luis Malpica, Carlos Chiattone

Blood (2024) 144 (Supplement 1): 1692.

https://doi.org/10.1182/blood-2024-211164

Published: 2024

Journal Articles

Treatment Patterns and Real World Outcomes with Clinical Trials for Patients with Follicular Lymphoma across Lines of Therapy

Neha Akkad, Amy Ayers, Kumudha Balakrishnan, Loretta Nastoupil, Dai Chihara, Luis Malpica, Paolo Strati, Ziyi Li, Christopher R. Flowers

Blood (2024) 144 (Supplement 1): 4396.

https://doi.org/10.1182/blood-2024-201804

Published: 2024

Journal Articles

Risk Analysis of Cytokine Release Syndrome, Immune Effector Cell- Associated Neurotoxicity Syndrome, and Immune Effector Cell- Associated Hemophagocytic Lymphohistiocytosis-like Syndrome in BiTE Therapy Vs CAR-T Therapy Using Real World Data

Alexandra Elias, Rishab Prakash, Ranjit Nair, Luis Malpica, Hun Ju Lee, Eguono Maples, Samantha Carlson, Luis E. Fayad, Krina K. Patel, Sairah Ahmed, Swaminathan P Iyer

Blood (2024) 144 (Supplement 1): 611.

https://doi.org/10.1182/blood-2024-212332

Published: 2024

Journal Articles

An Integrated Spatial, Codex, and Genomic Analysis Predicts Responsiveness and Survival in the Phase II Combination of Pembrolizumab and Romidepsin in PTCL

Ranjit Nair, Daniela E. Duenas, Jingjing Liu, Rishab Prakash, Chen Zhou, Ayse A Koksoy, Jie Xu, Salome A McAllen, Luis Malpica, Raja Luthra, Francisco Vega, Roberto N. Miranda, Jianhua Zhang, L. Jeffrey Medeiros, Cara L Haymaker, Christopher R. Flowers, Sattva S. Neelapu, Swami P. Iyer

Blood (2024) 144 (Supplement 1): 455.

https://doi.org/10.1182/blood-2024-211900

Published: 2024

Journal Articles

Developing Novel Cellular Therapies for Cutaneous T Cell Lymphoma (CTCL): Combining Immunopeptidomics and Endogenous T Cell (ETC) Therapy Platforms to Identify and Target Shared CTCL-Associated Antigens

Casey Bermack, Ke Pan, Yulun Chiu, Luis Malpica, Swaminathan P Iyer, Christopher R. Flowers, Cassian Yee

Blood (2024) 144 (Supplement 1): 3435.

https://doi.org/10.1182/blood-2024-207926

Published: 2024

Journal Articles

Outcomes after Allogeneic Stem-Cell Transplant in Patients with High-Risk Large-Cell Transformation of Mycosis Fungoides (MF-LCT)

Kunhwa Kim, Auris O Huen, Julia Dai, Rishabh Lohray, Bouthaina S. Dabaja, Jillian R. Gunther, Susan Y. Wu, Carlos P Torres-Cabala, Ranjit Nair, Luis Malpica, Yago Nieto, Jeremy Ramdial, Chitra Hosing, Samer A. Srour, Swaminathan P Iyer

Blood (2024) 144 (Supplement 1): 7448.

https://doi.org/10.1182/blood-2024-212007

Published: 2024

Journal Articles

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Blood (2024) 144 (Supplement 1): 6452.

https://doi.org/10.1182/blood-2024-198823

Published: 2024

Journal Articles

Brentuximab Associated Guillain-Barré Syndrome (BV-GBS): Case Series and a Review of Pharmacovigilance FDA Adverse Reporting System (FAERS)

Roshini Pradeep, Zeynep Nazli Benekli, Ranjit Nair, Luis Malpica, Hun Ju Lee, Eguono Maples, Samantha Carlson, Luis E. Fayad, Sairah Ahmed, Swami P. Iyer

Blood (2024) 144 (Supplement 1): 7776.

https://doi.org/10.1182/blood-2024-202119

Published: 2024

Journal Articles

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Blood (2024) 144 (Supplement 1): 3038.

https://doi.org/10.1182/blood-2024-206042

Published: 2024

Journal Articles

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Hun Ju Lee, Gregory Ravizzini, Eslam Aboismail, Jenna Wixom, Jared Henderson, Luis E. Fayad, Sairah Ahmed, Ranjit Nair, Jason R. Westin, Swaminathan P Iyer, Chijioke Nze, Ajlan Al Zaki, Francisco Vega, Michael Wang, Christopher R. Flowers, Luis Malpica

Blood (2024) 144 (Supplement 1): 1674.3.

https://doi.org/10.1182/blood-2024-212005

Published: 2024

Journal Articles

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

Fabiola Valvert, Omar Eduardo Fernandez Vargas, Sally Paredes, Luís Alberto de Pádua Covas Lage, Luis Mario Villela Martinez, Jose Marcial Macias Abasto, Victoria Irigoin, Cesar Camilo Carias Alvado, Juan C Barrios, Brenda Lizeth Acosta Maldonado, Denisse Castro, Betty Ramos Condori, Juliana Pereira, Silvia Rivas-Vera, Brady Beltran, Luis Malpica

Blood (2024) 144 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2024-211049

Published: 2024

Journal Articles

T-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis Has Worse Survival When Compared to T-Cell Lymphoma: A Retrospective Analysis from a Single Tertiary Center

Blood (2024) 144 (Supplement 1): 6420.

https://doi.org/10.1182/blood-2024-211482

Published: 2024

Journal Articles

Large Cell Transformation in Mycosis Fungoides & Sezary Syndrome: An Analysis of 445 Cases

Blood (2024) 144 (Supplement 1): 1679.

https://doi.org/10.1182/blood-2024-209213

Published: 2024

Journal Articles

Utility of PET/CT Imaging in Predicting Outcomes of Patients with Lymphoid Malignancy-Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis from a Single Tertiary Center

Rishab Prakash, James Long, Benjamin Mescher, Paul Edelkamp, Jr., Mark Knafl, Jeff Jin, Trey Kell, Naveen Garg, Ajlan Al Zaki, Dai Chihara, Luis Malpica, Ranjit Nair, Swaminathan P Iyer

Blood (2024) 144 (Supplement 1): 5127.

https://doi.org/10.1182/blood-2024-211892

Published: 2024

Journal Articles

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma

Alexandra Elias, Mario L. Marques-Piubelli, Ranjit Nair, Rishab Prakash, Sairah Ahmed, Luis Malpica, Hun Ju Lee, Jie Xu, Christopher R. Flowers, Sattva S. Neelapu, Francisco Vega, Roberto Miranda, Swami P. Iyer

Blood (2023) 142 (Supplement 1): 1714.

https://doi.org/10.1182/blood-2023-187939

Published: 2023

Journal Articles

Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Gastric MALT Lymphoma

Jillian Gunther, Jie Xu, Manoop S Bhutani, Paolo Strati, Penny Fang, Susan Wu, Bouthaina S. Dabaja, Wenli Dong, Priya Bhosale, Christopher R. Flowers, Ranjit Nair, Luis Malpica, Preetesh Jain, Sattva S. Neelapu, Maria Alma Rodriguez, Dai Chihara, Loretta J. Nastoupil, Chelsea Camille Pinnix

Blood (2023) 142 (Supplement 1): 298.

https://doi.org/10.1182/blood-2023-181757

Published: 2023

Journal Articles

Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma

Jason Westin, Ranjit Nair, Luis Fayad, Swami P. Iyer, Luis Malpica, Sattva S. Neelapu, Felipe Samaniego, Raphael Eric Steiner, Paolo Strati, Shivon Mathew, Donna Griffith, Loretta J. Nastoupil, Wirt Montinez, Maria Alma Rodriguez, Frederick Hagemeister, Lei Feng, Francisco Vega, Christopher R. Flowers, Sairah Ahmed

Blood (2023) 142 (Supplement 1): 1721.

https://doi.org/10.1182/blood-2023-191123

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

NARROW

Central Nervous System Involvement in Aggressive ATLL: Can We Predict the Risk in a Devastating Complication? Epidemiology and Clinical Features from Latin America. a Collaborative Study from Grupo De Estudio Latino-Americano De Linfoproliferativo (GELL) & T-Cell Brazil Project (TCBP)

The Impact of Social Determinants and Diagnostic Inequities in Hodgkin Lymphoma Outcomes: A Comparative Analysis of South America and the United States

The Number of Extranodal Sites Matters! a Proposal for a Feasible Prognostic Model in Nodal PTCL. a Collaborative Study grupo De Estudio Latino-Americano De Linfoproliferativos (GELL) & T-Cell Brazil Project (TCBP)

Treatment Patterns and Real World Outcomes with Clinical Trials for Patients with Follicular Lymphoma across Lines of Therapy

Risk Analysis of Cytokine Release Syndrome, Immune Effector Cell- Associated Neurotoxicity Syndrome, and Immune Effector Cell- Associated Hemophagocytic Lymphohistiocytosis-like Syndrome in BiTE Therapy Vs CAR-T Therapy Using Real World Data

An Integrated Spatial, Codex, and Genomic Analysis Predicts Responsiveness and Survival in the Phase II Combination of Pembrolizumab and Romidepsin in PTCL

Developing Novel Cellular Therapies for Cutaneous T Cell Lymphoma (CTCL): Combining Immunopeptidomics and Endogenous T Cell (ETC) Therapy Platforms to Identify and Target Shared CTCL-Associated Antigens

Outcomes after Allogeneic Stem-Cell Transplant in Patients with High-Risk Large-Cell Transformation of Mycosis Fungoides (MF-LCT)

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Brentuximab Associated Guillain-Barré Syndrome (BV-GBS): Case Series and a Review of Pharmacovigilance FDA Adverse Reporting System (FAERS)

Acalabrutinib with Rituximab Is Highly Effective First Line Treatment for Older Patients with Mantle Cell Lymphoma

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

T-Cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis Has Worse Survival When Compared to T-Cell Lymphoma: A Retrospective Analysis from a Single Tertiary Center

Large Cell Transformation in Mycosis Fungoides & Sezary Syndrome: An Analysis of 445 Cases

Utility of PET/CT Imaging in Predicting Outcomes of Patients with Lymphoid Malignancy-Associated Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis from a Single Tertiary Center

Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma

Ultra Low Dose 4 Gy Radiation for Definitive Therapy of Gastric MALT Lymphoma

Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only